Role of epigenetic changes in hematological malignancies

Ulrich Lehmann1, Kai Brakensiek, Hans Kreipe

  • 1Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, 30625, Hannover, Germany. Lehmann.Ulrich@MH-Hannover.de

Annals of Hematology
|April 6, 2004
PubMed

Insights

Tumor suppressor gene inactivation, crucial in cancer, can occur via DNA methylation, an epigenetic change. This review explores DNA methylation alterations in blood cancers and their therapeutic and prognostic implications.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Inactivation of tumor suppressor genes is a key step in cancer development.
  • Besides genetic mutations, epigenetic alterations like DNA methylation can silence these genes.
  • DNA methylation involves adding a methyl group to cytosine residues in gene promoter regions.

Purpose of the Study:

  • To review the role of epigenetic phenomena, specifically DNA methylation, in cancer.
  • To detail the molecular mechanisms of DNA methylation.
  • To examine DNA methylation patterns in hematopoietic malignancies and their clinical relevance.

Main Methods:

  • Literature review of epigenetic phenomena and DNA methylation.
  • Analysis of studies reporting DNA methylation patterns in blood cancers.
  • Discussion of therapeutic and prognostic implications.

Main Results:

  • DNA methylation is a significant mechanism for functional inactivation of tumor suppressor genes.
  • Aberrant DNA methylation patterns are widespread in various hematopoietic malignancies.
  • These epigenetic alterations have potential as biomarkers for prognosis and therapeutic targets.

Conclusions:

  • Epigenetic dysregulation, particularly DNA methylation, is fundamental to the pathogenesis of blood cancers.
  • Understanding these alterations offers new avenues for cancer therapy and predicting patient outcomes.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...